Comprehensive assessment of the association between estrogen receptor of alpha polymorphisms and the risk of prostate cancer: evidence from a meta-analysis

Guang Li; Meng Yang; Xian Li; Shixiong Deng

doi:10.18632/oncotarget.21117

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Meta-Analysis:

Comprehensive assessment of the association between estrogen receptor of alpha polymorphisms and the risk of prostate cancer: evidence from a meta-analysis

Guang Li, Meng Yang, Xian Li _ and Shixiong Deng

PDF | HTML | How to cite

Oncotarget. 2017; 8:102310-102320. https://doi.org/10.18632/oncotarget.21117

Metrics: PDF 1486 views | HTML 1569 views | ?

Abstract

Guang Li1,*, Meng Yang2,*, Xian Li3 and Shixiong Deng1

1Laboratory of Forensic Medicine and Bioinformatics, Chongqing Medical University, Chongqing, China

2Research Department, Children Hospital of Chongqing Medical University, Chongqing, China

3Laboratory of Biomedical Engineering, Chongqing Medical University, Chongqing, China

*These authors contributed equally to this work

Correspondence to:

Xian Li, email: [email protected]

Shixiong Deng, email: [email protected]

Keywords: estrogen receptor of alpha, polymorphisms, prostate cancer, meta-analysis

Received: June 22, 2017 Accepted: August 27, 2017 Published: September 21, 2017

ABSTRACT

We performed a meta analysis to access the relationship of estrogen receptor of alpha (ESRα) polymorphisms with the risk of prostate cancer (PC). Twenty-four case-control studies (including 5477 cases and 10708 controls) were recruited for meta-analysis. The strongest association with the risk of PC was observed between ESRα rs9340799 and rs2234693 under the two genotypic models of allele and codominance in the overall population (p < 0.05). Under the subgroup analysis of ethnicity, we observed that ESRα rs9340799 was significantly associated with the susceptibility to PC in European population (AvsG, p = 0.000; AAvsGG, p = 0.002), while there was no difference in Asian (AvsG, p = 0.493; AAvsGG, p = 0.736) or African population (AvsG, p = 0.800; AAvsGG, p = 0.788). The results also showed that significant association between rs2234693 and the susceptibility to PC in European (CvsT, p = 0.004; CCvsTT, p = 0.001) and Asian population (CvsT, p = 0.004; CCvsTT, p = 0.003), but not in African population (CvsT, p = 0.636; CCvsTT, p = 0.669). The meta-analysis indicated that ESRα rs9340799 and rs2234693 might contribute to susceptibility and development of PC in European population.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21117

Publication Alerts

Meta-Analysis:

Comprehensive assessment of the association between estrogen receptor of alpha polymorphisms and the risk of prostate cancer: evidence from a meta-analysis

Abstract